Market News & Trends
Actinium Announces Selection of Zevacor for Clinical Production & Supply Pivotal Phase III Trial
Actinium Pharmaceuticals, Inc. recently announced the company has entered into an agreement with Zevacor Pharma, Inc. (formerly IBA Molecular North America, Inc.) for the clinical…
World Excipients Market Expected to Reach $6.4 Billion by 2020
A new report published by Allied Market Research titled World Excipients Market-Opportunities and Forecasts, 2014-2020 projects that the world excipients market would reach $6.4 billion…
Global Viral Infections Market to Reach $117.6 Billion
The global viral infections market will grow from $74 billion in 2014 to $117.6 billion by 2021, representing a compound annual growth rate of 6.8%,…
REMD Biotherapeutics Announces Dosing of First Type 1 Diabetes Patient With Glucagon Receptor Monoclonal Antibody
REMD Biotherapeutics, Inc., together with its subsidiary, Beijing CoSci-REMD Bio Med-Tech Co, Ltd (CoSci-REMD Bio), recently announced that the first patient with type 1 diabetes…
Labome Releases Validated Antibody Database Version 2.2
Antibodies form an essential part of the immune defence against microbes and have been explored as therapeutics and diagnostics due to their ability to bind…
Human Vaccines Project Launches San Diego Research Hub
Four scientific institutions – University of California, San Diego, J. Craig Venter Institute, La Jolla Institute for Allergy and Immunology and The Scripps Research Institute…
Galapagos Initiates Phase IIa Study
Galapagos NV recently announced the start of its exploratory Phase IIa study with GLPG1690 in idiopathic pulmonary fibrosis (IPF) patients, named FLORA, a randomized, double-blind,…
New Study Finds Thousands of PE Patients May Later Develop Life-Threatening Form of PH
Results from a retrospective claims database study of pulmonary embolism (PE) patients published today in the American Journal of Medicine indicate that US physicians may…
Adaptimmune Announces FDA Acceptance of IND Application
Adaptimmune Therapeutics plc recently announced that the US FDA has accepted the company’s investigational new drug (IND) application for autologous genetically modified T-cells expressing affinity…
WellSpring Pharma Services Completes $3-Million Capital Investment & Forms New Partnership
WellSpring Pharma Services, leading specialists in formulation, development and manufacturing for a wide range of solid, semi-solid and non-sterile liquid products, has announced a $3…
Huge Opportunities Remain for Premium-Priced Tyrosine Kinase Inhibitors in Pulmonary Arterial Hypertension
The Pulmonary Arterial Hypertension (PAH) space, which is currently burdened by significant unmet need, could benefit substantially from a class of drugs known as Tyrosine…
Paragon Bioservices Recognized as Best Contract Manufacturing Organization
Paragon Bioservices, Inc., a global leader in the manufacturing of biopharmaceuticals and vaccines, announced today that it was selected as the "Best Contract Manufacturing Organization"…
Crown Bioscience Strengthens Immuno-Oncology Capabilities With HuGEMM
Crown Bioscience, a wholly owned subsidiary of Crown Bioscience International (TWSE: ticker 6554), a global drug discovery and development services company providing translational platforms to…
Rexahn Pharmaceuticals Announces Initiation of Phase Ib/IIa Clinical Trial of Novel Oral Anti-Cancer Therapeutic
Rexahn Pharmaceuticals, Inc. recently announced that is has enrolled the first patient in its Phase Ib/IIa clinical trial of a the novel oral anti-cancer agent,…
Advaxis Combination Trial With MedImmune Completes First Dose-Escalation Cohort
Advaxis, Inc. recently announced its combination study with MedImmune, the global biologics research and development arm of AstraZeneca, has completed the first dose-escalation cohort in…
Brammer Biopharmaceuticals & Florida Biologix Merge, Creating Leading CDMO
Brammer Biopharmaceuticals recently announced its merger with Florida Biologix to create the best-in-class cell and gene therapy biologics contract development and manufacturing organization (CDMO). The…
Actinium Receives Orphan Drug Designation From FDA
Actinium Pharmaceuticals, Inc. recently announced that the US Food and Drug Administration (FDA) has granted orphan drug designation for Iomab-B, a radioimmunotherapeutic that conditions relapsed…
MilliporeSigma's CRISPR Epigenetic Activator Named on Top 10 Innovation List
The life science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the United States and Canada, recently announced that The Scientist magazine…
SGS & DiscoverX Enter Collaboration Agreement
SGS has entered into a collaboration with DiscoverX to work together to provide simple and qualified assays for functional comparability, for use in quality control…
Exclusive: Capsugel Prepares to Explore Sale or IPO
By: Carl O’Donnell & Greg Roumeliotis Capsugel, a U.S. maker of capsule products and other drug delivery systems, is preparing to explore a sale or…
